Sibutramine hydrochloride monohydrate is a pharmaceutical substance classified as a monoamine reuptake inhibitor, which was historically utilized as an appetite suppressant for the management of obesity… Read more
Sibutramine hydrochloride monohydrate is a pharmaceutical substance classified as a monoamine reuptake inhibitor, which was historically utilized as an appetite suppressant for the management of obesity and weight loss. Despite being withdrawn from many markets due to potential cardiovascular risks, this compound remains a subject of ongoing research and forensic investigation. Analytical laboratories require high-quality reference standards of this drug and its related compounds, including metabolites such as didesmethylsibutramine hydrochloride and various degradation impurities, to support rigorous testing protocols. These reference materials are critical for impurity profiling, allowing researchers to accurately identify and quantify substances in complex matrices. Furthermore, stable isotope labelled compounds are indispensable for method validation and as internal standards in mass spectrometry-based assays, ensuring precision in analytical studies where tracking specific sibutramine derivatives is necessary for maintaining strict quality control and regulatory compliance.
